Clinical Trials

Showing trials with last updates posted in 2026.

NCT05579366 | RECRUITING | PHASE1/PHASE2
884 participants

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2022-12-07
Completion:
2027-07-31
Conditions
  • High Grade Epithelial Ovarian Cancer
  • High Grade Serous Ovarian Cancer
  • Primary Peritoneal Carcinoma
  • Fallopian Tube Cancer
  • Endometrial Cancer
  • Non-small Cell Lung Cancer
  • Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)
  • Mesothelioma
  • Breast Adenocarcinoma
  • Triple Negative Breast Cancer
  • Hormone Receptor-positive/Her2 Negative Breast Cancer
  • Platinum-resistant Ovarian Cancer (PROC)
  • Platinum Sensitive Ovarian Cancer (PSOC)
  • Primary Refractory Ovarian Cancer
  • Uterine Cancer
Interventions
  • DRUG
No Results Yet
NCT05564390 | RECRUITING | PHASE2
2000 participants

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-06-18
Completion:
2029-05-15
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
  • Acute Myeloid Leukemia Post Cytotoxic Therapy
  • Acute Myeloid Leukemia, Myelodysplasia-Related
  • Myelodysplastic Syndrome
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT05554328 | RECRUITING | PHASE2
165 participants

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2023-04-25
Completion:
2028-10-01
Conditions
  • Recurrent Endometrial Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05412901 | SUSPENDED | NA
170 participants

Scaffolding of Brain Operations

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2022-04-10
Completion:
2027-06-30
Conditions
  • Behavioral Performance
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page